SCHEMBL17829090

SCHEMBL17829090

c1ccc(-c2nc(-n3c4ccc(-n5c6ccccc6c6ccccc65)cc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)nc3c2ccc2ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.37
KDM4E B2RXH2 3/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
NPY5R Q15761 1/20 0.34
LMNA P02545 2/20 0.33
MAOA P21397 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
KHK P50053 1/20 0.31
TLR8 Q9NR97 1/20 0.30
MEN1 O00255 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18058352 1.00 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL17829110 0.98 L3MBTL1 (0.36) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL17829053 0.95 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL17904208 0.93 KDM4E (0.40) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL18058336 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL23026933 0.92 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL18026397 0.91 KDM4E (0.41) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL19271601 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL24027752 0.91 L3MBTL1 (0.34) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21281904 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 L3MBTL1 271/4885KDM4E 2236/4885ATM 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.